Risperdal Safety Protocol Evaluation Consta Treatment; A Post Authorisation Safety Survey With RISPERDAL CONSTA TM
Phase of Trial: Phase IV
Latest Information Update: 15 Oct 2010
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Acronyms RiSPECT
- Sponsors Janssen Pharmaceutica
- 19 Oct 2007 Status changed from in progress to completed.
- 18 Apr 2007 New trial record.